A new experimental cervical cancer test by Qiagen NV has been developed that may help fight off the disease in developing countries around the world
It is being reported that a new test to look for cervical cancer has been developed, that will help reduce the number of cancer cases in developing countries.
Cervical cancer is the second leading cause of cancer related death in women world wide, only trailing breast cancer.
In developed countries, pap smears are used to check for cervical cancer, but this test is not always available in developing countries.
The new rapid test checks for the presence of the HPV that is associated with cervical cancer, and in clinical trials was effective in up to 90% of cases.
careHPV is the name of the HPV test, that can identify up to 14 HPV strains that put women at risk of cervical cancer.
“If women 30 years and older could be screened at least once in their lifetimes with such a test, and appropriate treatment administered at the same visit, public health programmes would be affordable and deaths from cervical cancer would be reduced by a third,” said one of the researchers, John Sellors, professor of family medicine at the McMaster University in Canada.
The researchers published their study findings in the Lancet Oncology.